Coronary heart disease secondary prevention beta-blockers: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

11 January 2013

10 January 2013

8 January 2013

14 November 2012

  • curprev 18:4818:48, 14 November 2012Esther Lee talk contribs 7,169 bytes +70 /* Beta Blockers (DO NOT EDIT) {{cite journal| author=Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.| title=AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Va...
  • curprev 18:4518:45, 14 November 2012Esther Lee talk contribs 7,099 bytes +93 /* Beta Blockers (DO NOT EDIT) {{cite journal| author=Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.| title=AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Va...
  • curprev 16:3916:39, 14 November 2012Esther Lee talk contribs 7,006 bytes +3,722 No edit summary

11 October 2012

  • curprev 18:0018:00, 11 October 2012Esther Lee talk contribs 3,284 bytes +2 /* ACC / AHA 2011 Guidelines - Coronary Heart Disease - Secondary Prevention with Beta Blockers (DO NOT EDIT) {{cite journal| author=Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.| title=AHA/ACCF Secondary Prevention and...
  • curprev 17:1117:11, 11 October 2012Esther Lee talk contribs 3,282 bytes +3,282 Created page with "__NOTOC__ {{Coronary heart disease}} {{CMG}} == Overview == ==Beta Blockers== ===ACC / AHA 2011 Guidelines - Coronary Heart Disease - Secondary Prevention with Beta Blockers ..."